Nanosensor Characterization and CRISPR-Cas Mediated Urine Biomarker Test for Cancer Diagnostics
Please note that all translations are AI generated. Click here for the English version.
57 Views
•
03:23 min
•
December 8th, 2023
DOI :
December 8th, 2023
•Audrey E. Van Heest1, Feiyang Deng1, Renee T. Zhao2, Nour Saida Harzallah2,3, Heather E. Fleming3,4, Sangeeta N. Bhatia2,3,4,5,6,7,8, Liangliang Hao1,2,3
1Department of Biomedical Engineering, Boston University, 2Institute for Medical Engineering and Science, Massachusetts Institute of Technology, 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 4Howard Hughes Medical Institute, 5Broad Institute of Massachusetts Institute of Technology and Harvard, 6Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 7Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 8Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
Transcrição
SOBRE A JoVE
Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados